IFF to Showcase Science-backed Low Nitrite Excipients at Excipient World 2024
At Excipient World 2024, IFF's Pharma Solutions division will showcase science-backed low nitrite excipients for pharmaceutical manufacturers. These solutions aim to mitigate nitrosamine risk and enhance patient outcomes. With expertise in cellulosic excipients, IFF's Avicel® PH LN and METHOCEL™ range are proven to reduce nitrosamines. Attendees can explore regulatory compliance, quality, and product innovation benefits of IFF's excipients.
IFF's innovative low nitrite excipients offer science-backed solutions for pharmaceutical manufacturers to enhance patient outcomes.
Pharma Solutions division's expertise in cellulosic excipients, such as Avicel® PH LN and METHOCEL™, provides effective nitrosamine reduction in model formulations.
IFF's excipients can help elevate drug formulations, optimize drug delivery, and contribute to patient well-being by ensuring safer pharmaceutical formulations.
- None.
Experts will present risk assessment strategies for nitrite detection and quality evaluation to promote safer pharmaceutical formulations with better patient outcomes
Nitrosamine risk assessment and control have become an integral part of pharmaceutical drug product development and quality evaluation. With more than 70 years of expertise in cellulosic excipients, IFF's pioneering, leading brands ─ Avicel® PH LN, a robust low nitrite microcrystalline cellulose (MCC) and METHOCEL™ range of water-soluble cellulose ethers are proven effective in reducing nitrosamines in model formulations.
"As the pharmaceutical landscape evolves, it is important to address and solve any challenges associated with nitrosamine risk," said Angela Strzelecki, president, Pharma Solutions, IFF. "Collaborating with an excipient manufacturer with vital expertise, and robust formulation and analytical capabilities enables drug developers to confidently and efficiently incorporate low nitrite excipients into their formulations."
Attendees will have the opportunity to meet with IFF experts and discuss areas such as regulatory compliance, quality, consistency, product innovation, and how the Company's state-of-the-art excipients can help elevate drug formulations, optimize drug delivery, and ultimately contribute to patient well-being.
IFF will share nitrosamine analytical insights and the latest scientific advancements during the following informative sessions:
- On May 14, 11.15 a.m.–12.00 p.m. ET, Sun Ballroom, Stage 2, Koudi Zhu, analytical scientist, Pharma Solutions will present on nitrite detection and ensuring safer pharmaceutical formulations, titled "Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients".
- From May 13-15, Priscilla Zawislak, IFF senior manager, Scientific and Public Affairs, and past chair of IPEC-Americas, will present the importance and role of excipients in oral drug delivery, and regulatory and quality considerations relating to excipients at the Excipients 101 workshop and other educational sessions.
Register here to schedule a meeting at Excipient World 2024.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partner with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Contact:
Lisa Luke
Global Communications Director
1 302-927-9234
Lisa.Luke@iff.com
SOURCE IFF
FAQ
What will IFF showcase at Excipient World 2024?
Which innovative excipients will IFF highlight at the event?
What benefits can attendees of Excipient World 2024 expect from IFF's excipients?
